Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Spero Therapeutics stock
Learn how to easily invest in Spero Therapeutics stock.
Spero Therapeutics Inc is a biotechnology business based in the US. Spero Therapeutics shares (SPRO) are listed on the NASDAQ and all prices are listed in US Dollars. Spero Therapeutics employs 41 staff and has a trailing 12-month revenue of around $9.9 million.
How to buy shares in Spero Therapeutics
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – SPRO – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Spero Therapeutics stock price (NASDAQ: SPRO)Use our graph to track the performance of SPRO stocks over time.
Spero Therapeutics shares at a glance
|Latest market close||$1.97|
|52-week range||$0.68 - $19.87|
|50-day moving average||$0.93|
|200-day moving average||$5.54|
|Wall St. target price||$11.25|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-3.26|
Buy Spero Therapeutics shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Spero Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Spero Therapeutics price performance over time
|1 week (2022-09-23)||1.97|
|1 month (2022-08-30)||123.86%|
|3 months (2022-06-30)||165.86%|
|6 months (2022-03-26)||N/A|
|1 year (2021-09-30)||-89.30%|
|2 years (2020-09-30)||-82.35%|
|3 years (2019-09-30)||10.6|
|5 years (2017-09-26)||N/A|
Spero Therapeutics financials
|Revenue TTM||$9.9 million|
|Gross profit TTM||$-42,107,000|
|Return on assets TTM||-64.45%|
|Return on equity TTM||-179.55%|
|Market capitalisation||$69.1 million|
TTM: trailing 12 months
Spero Therapeutics share dividends
We're not expecting Spero Therapeutics to pay a dividend over the next 12 months.
Spero Therapeutics share price volatility
Over the last 12 months, Spero Therapeutics's shares have ranged in value from as little as $0.68 up to $19.87. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Spero Therapeutics's is 1.8689. This would suggest that Spero Therapeutics's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Spero Therapeutics overview
Spero Therapeutics, Inc. , a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product candidates include tebipenem pivoxil hydrobromide (HBr), an oral carbapenem-class antibiotic to treat complicated urinary tract infections, including pyelonephritis for adults; SPR206, a direct acting IV-administered agent to treat MDR Gram-negative bacterial infections in the hospital; and SPR720, an oral antibiotic for the treatment of non-tuberculous mycobacterial pulmonary disease. It has license agreement with Meiji Seika Pharma Co. , Ltd. to support the development of tebipenem HBr; license agreement with Everest Medicines to develop, manufacture, and commercialize SPR206 in Greater China, South Korea, and Southeast Asian countries; collaboration agreement with Bill & Melinda Gates Medical Research Institute to develop SPR720 for the treatment of lung infections caused by Mycobacterium tuberculosis; and license agreement with Vertex Pharmaceuticals Incorporated for patents relating to SPR720, as well as SPR719, an active metabolite. The company was founded in 2013 and is headquartered in Cambridge, Massachusetts.
Spero Therapeutics in the news
This Infection-Fighting Biotech Is Recovering Nicely
Spero (SPRO) Skyrockets 168% on Licensing Deal With GSK
GSK picks up troubled Spero drug for nearly $300M, takes stake in company
Frequently asked questionsWhat percentage of Spero Therapeutics is owned by insiders or institutions?
Currently 15.772% of Spero Therapeutics shares are held by insiders and 57.843% by institutions. How many people work for Spero Therapeutics?
Latest data suggests 41 work at Spero Therapeutics. When does the fiscal year end for Spero Therapeutics?
Spero Therapeutics's fiscal year ends in December. Where is Spero Therapeutics based?
Spero Therapeutics's address is: 675 Massachusetts Avenue, Cambridge, MA, United States, 02139 What is Spero Therapeutics's ISIN number?
Spero Therapeutics's international securities identification number is: US84833T1034 What is Spero Therapeutics's CUSIP number?
Spero Therapeutics's Committee on Uniform Securities Identification Procedures number is: 84833T103
More guides on Finder
Alternatives to Webull
Looking for a discount broker like Webull that offers something different? Here are some of the top alternatives to consider.
Best renewable energy stocks for 2022
Here are the best renewable energy stocks that should be on your radar to help you grow your green portfolio
Here are 6 manganese stocks that should be on your radar as EV batteries create new demand.
The best dividend stocks for 2022
Our list of 10 dividend stocks to watch in 2022.
How to buy YanGuFang International Group (YGF) stock when it goes public
Everything we know about the YanGuFang International Group IPO, plus information on how to buy in.
What are the FAANG stocks and how do you invest in them?
Looking to invest in tech? Here’s how to buy shares in the major tech companies, known as FAANG stocks.
How to buy soccer stocks
A simple guide to buying stocks in your favorite European soccer team.
How to buy Juventus stock
Steps to owning and managing JUVE, with 24-hour and historical pricing before you buy.
How to buy AS Roma stock
Steps to owning and managing ASR, with 24-hour and historical pricing before you buy.
How to buy Borussia Dortmund stock
Steps to owning and managing BVB, with 24-hour and historical pricing before you buy.
Ask an Expert